253 related articles for article (PubMed ID: 25186025)
21. Rosacea: part II. Topical and systemic therapies in the treatment of rosacea.
Two AM; Wu W; Gallo RL; Hata TR
J Am Acad Dermatol; 2015 May; 72(5):761-70; quiz 771-2. PubMed ID: 25890456
[TBL] [Abstract][Full Text] [Related]
22. Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 2: a status report on topical agents.
Del Rosso JQ; Thiboutot D; Gallo R; Webster G; Tanghetti E; Eichenfield L; Stein-Gold L; Berson D; Zaenglein A
Cutis; 2013 Dec; 92(6):277-84. PubMed ID: 24416742
[TBL] [Abstract][Full Text] [Related]
23. Major pathophysiological correlations of rosacea: a complete clinical appraisal.
Vemuri RC; Gundamaraju R; Sekaran SD; Manikam R
Int J Med Sci; 2015; 12(5):387-96. PubMed ID: 26005373
[TBL] [Abstract][Full Text] [Related]
24. A case report of combination treatment with potassium-titanyl phosphate laser and brimonidine topical gel in erythematotelangiectatic rosacea.
Hofmann MA; Kokolakis G
J Cosmet Laser Ther; 2017 Aug; 19(4):222-224. PubMed ID: 28139145
[TBL] [Abstract][Full Text] [Related]
25. Update on the Management of Rosacea.
Weinkle AP; Doktor V; Emer J
Plast Surg Nurs; 2015; 35(4):184-202. PubMed ID: 26605825
[TBL] [Abstract][Full Text] [Related]
26. Rosacea and its topical management.
Gooderham M
Skin Therapy Lett; 2009 Feb; 14(2):1-3. PubMed ID: 19330270
[TBL] [Abstract][Full Text] [Related]
27. Devices and topical agents for rosacea management.
Mansouri Y; Goldenberg G
Cutis; 2014 Jul; 94(1):21-5. PubMed ID: 25101340
[TBL] [Abstract][Full Text] [Related]
28. Optical coherence tomography imaging of erythematotelangiectatic rosacea during treatment with brimonidine topical gel 0.33%: a potential method for treatment outcome assessment.
Urban J; Siripunvarapon AH; Meekings A; Kalowitz A; Markowitz O
J Drugs Dermatol; 2014 Jul; 13(7):821-6. PubMed ID: 25007365
[TBL] [Abstract][Full Text] [Related]
29. Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS).
Del Rosso JQ; Tanghetti E; Webster G; Stein Gold L; Thiboutot D; Gallo RL
J Clin Aesthet Dermatol; 2019 Jun; 12(6):17-24. PubMed ID: 31360284
[No Abstract] [Full Text] [Related]
30. Ivermectin cream for rosacea.
Drug Ther Bull; 2015 Nov; 53(11):129-31. PubMed ID: 26563877
[TBL] [Abstract][Full Text] [Related]
31. Update on the management of rosacea.
Weinkle AP; Doktor V; Emer J
Clin Cosmet Investig Dermatol; 2015; 8():159-77. PubMed ID: 25897253
[TBL] [Abstract][Full Text] [Related]
32. A Review of the Current Modalities for the Treatment of Papulopustular Rosacea.
McGregor SP; Alinia H; Snyder A; Tuchayi SM; Fleischer A; Feldman SR
Dermatol Clin; 2018 Apr; 36(2):135-150. PubMed ID: 29499797
[TBL] [Abstract][Full Text] [Related]
33. Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS).
Del Rosso JQ; Tanghetti E; Webster G; Stein Gold L; Thiboutot D; Gallo RL
J Clin Aesthet Dermatol; 2020 Jun; 13(6 Suppl):S17-S24. PubMed ID: 33282106
[No Abstract] [Full Text] [Related]
34. Topical and oral therapeutic approach to rosacea.
Helfrich YR; Maier LM
Semin Cutan Med Surg; 2016 Jun; 35(2):74-8. PubMed ID: 27416312
[TBL] [Abstract][Full Text] [Related]
35. Multidisciplinary Consideration of Potential Pathophysiologic Mechanisms of Paradoxical Erythema with Topical Brimonidine Therapy.
Docherty JR; Steinhoff M; Lorton D; Detmar M; Schäfer G; Holmes A; Di Nardo A
Adv Ther; 2016 Nov; 33(11):1885-1895. PubMed ID: 27562835
[TBL] [Abstract][Full Text] [Related]
36. Needs survey of Canadian rosacea patients.
Shear NH; Levine C
J Cutan Med Surg; 1999 Apr; 3(4):178-81. PubMed ID: 10366390
[TBL] [Abstract][Full Text] [Related]
37. The role of brimonidine tartrate gel in the treatment of rosacea.
Jackson JM; Knuckles M; Minni JP; Johnson SM; Belasco KT
Clin Cosmet Investig Dermatol; 2015; 8():529-38. PubMed ID: 26566370
[TBL] [Abstract][Full Text] [Related]
38. Rosacea: recognition and management for the primary care provider.
Chalmers DA
Nurse Pract; 1997 Oct; 22(10):18, 23-8, 30. PubMed ID: 9355115
[TBL] [Abstract][Full Text] [Related]
39. The proposed inflammatory pathophysiology of rosacea: implications for treatment.
Millikan L
Skinmed; 2003; 2(1):43-7. PubMed ID: 14673323
[TBL] [Abstract][Full Text] [Related]
40. Treatment of erythemato-telangiectatic rosacea with brimonidine alone or combined with vascular laser based on preliminary instrumental evaluation of the vascular component.
Micali G; Dall'Oglio F; Verzì AE; Luppino I; Bhatt K; Lacarrubba F
Lasers Med Sci; 2018 Aug; 33(6):1397-1400. PubMed ID: 28889348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
